The Keystone Program in Personalized Kidney Cancer Therapy
Joseph R. Testa, Ph.D.
Co-Leader, Keystone Program in Personalized Kidney Cancer Therapy
Dr. Joseph R. Testa of Churchville, Pa., has been a prominent part of the Fox Chase Cancer Center research community for nearly twenty years. A cancer geneticist, Testa joined Fox Chase in 1989 as director of molecular cytogenetics, the branch of genetics concentrating on changes in chromosomes. Since 1982, he had been associate professor of pathology, medicine and oncology at the University of Maryland School of Medicine. Previously, he was chief of cytogenetics for the National Cancer Institute's Baltimore Cancer Research Program on the Maryland campus.
In addition to mesothelioma research, Testa has been widely recognized for his work on leukemia. He held a Special Fellowship from the Leukemia Society of America from 1982 to 1984 and a Leukemia Society of America Scholar Award from 1984 to 1990. In 1987, Testa received the Society's prestigious Stohlman Memorial Scholar Award, honoring him for his studies of chromosome alterations in acute leukemia. He received a 1999 Irving J. Selikoff Award for Cancer Research.
He was named a senior member of Fox Chase's medical science division in 1992.With his 1999 appointment as director of the human genetics program, he became a senior member of the division of population science. He has served on the editorial boards of four scientific journals.